Description
C5a Antibodyis available at Gentaur for Next week Delivery.
Description: Human complement C5a is a 74-amino acid glycopeptide generated during complement activation from the α-chain of complement C5. C5a is a potent chemotactic factor for human peripheral blood neutrophils and monocytes, and is believed to play an important role in a number of inflammatory conditions.
Immunogen Sequence:Recombinant human Complement C5a
Target Alternative Name:complement component 5a receptor 1, Complement component C5a complement component 5
Species Reactivities:Human
Tag Line:/
Formulation:30 µg (0.5 mg/ml) affinity purified rabbit polyclonal antibody in phosphate-buffered saline (PBS) containing 30% glycerol, 0.5% BSA, and 0.01% thimerosal.
Purification: Affinity purified
Application:Western blot
Positive Control:/
Application And Usages:Western blotting (0.5-4 µg/ml). However, the optimal concentrations should be determined individually. Recombinant human C5a can be used as a positive control (Cat.# 4995A-20).
Handling:The antibody solution should be gently mixed before use.
Additional Information
| Size: | 30 µg | 
| Antibody Target: | C5a | 
| Category: | C5a | 
| Lot Number: | 51295 | 
| Host: | Rabbit | 
| Antibody Type: | Polyclonal | 
| Isotype: | Rabbit IgG | 
| Accession Number: | P01031 | 
| Gene Id: | 727 | 
| Concentration: | 0.5 mg/ml | 
| Appearance: | Colorless liquid | 
| Form: | Liquid | 
| Storage Condition: | -20 °C | 
| Shipping Condition: | gel pack | 
| Shelf Life: | 12 months | 
| Country of Animal Origin: | China | 
| Country of Manufacture: | USA | 
| Usage: | For Research Use Only! Not to be used in humans. | 
| Western Blot Verified: | Verified | 
| Immunocytochemistry Verified: | Not Verified | 
| Immunofluorescence Verified: | Not Verified | 
| Immunoprecipitation Verified: | Not Verified | 
| ELISA Verified: | Not Verified | 
| ChIP Verified: | Not Verified | 
| Flow Cytometry Verified: | Not Verified | 
 
             
             
                                 
                                 
                                 
                         
                         
                         
                         
                                 
             
                                 
             
             
            